Home > Insider Trading > Filing (0001415889-21-000527)

Filing Details

Accession Number:: 0001415889-21-000527
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-02-03 19:10:54
Reporting Period:: 2021-02-01

Accepted Time:: 2021-02-03 19:10:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1604821	Natera Inc.	NTRA	Services-Medical Laboratories (8071)	010894487

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1711968	Leonard Steven Chapman	C/O Natera, Inc. 201 Industrial Rd Suite 410 San Carlos CA 94070	Chief Executive Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-02-01	525	$10.41	37,689	No	4	M	Direct
Common Stock	Acquisiton	2021-02-01	198	$10.73	37,887	No	4	M	Direct
Common Stock	Acquisiton	2021-02-01	443	$9.29	38,330	No	4	M	Direct
Common Stock	Acquisiton	2021-02-01	281	$13.01	38,611	No	4	M	Direct
Common Stock	Acquisiton	2021-02-01	1,688	$13.01	40,299	No	4	M	Direct
Common Stock	Acquisiton	2021-02-01	490	$20.27	40,789	No	4	M	Direct
Common Stock	Acquisiton	2021-02-01	215	$25.46	41,004	No	4	M	Direct
Common Stock	Disposition	2021-02-01	1,926	$107.70	39,078	No	4	S	Direct
Common Stock	Disposition	2021-02-01	1,914	$108.54	37,164	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2021-02-01	525	$0.00	525	$10.41
Common Stock	Stock Option (right to buy)	Disposition	2021-02-01	198	$0.00	198	$10.73
Common Stock	Stock Option (right to buy)	Disposition	2021-02-01	443	$0.00	443	$9.29
Common Stock	Stock Option (right to buy)	Disposition	2021-02-01	281	$0.00	281	$13.01
Common Stock	Stock Option (right to buy)	Disposition	2021-02-01	1,688	$0.00	1,688	$13.01
Common Stock	Stock Option (right to buy)	Disposition	2021-02-01	490	$0.00	490	$20.27
Common Stock	Stock Option (right to buy)	Disposition	2021-02-01	215	$0.00	215	$25.46

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
9,194	2027-06-08	No	4	M	Direct
3,865	2027-07-13	No	4	M	Direct
46,718	2028-03-08	No	4	M	Direct
52,531	2029-01-10	No	4	M	Direct
77,687	2029-01-10	No	4	M	Direct
58,572	2029-04-11	No	4	M	Direct
39,431	2030-03-26	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.40 to $108.03 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.05 to $108.82 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 21, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 12, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on January 2, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
This option becomes exercisable, if at all, upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price, based on the average closing price per share of the Issuer's common stock for a calendar month, calculated as of the last day of such calendar month. The first milestone is the Issuer's stock price equaling or exceeding the quotient of (i) $2,000,000,000 and (ii) the Issuer's outstanding shares as most recently reported on the Issuer's Form 10-Q or Form 10-K (the "Capitalization"). The second milestone is the Issuer's stock price equaling or exceeding the quotient of (i) $3,000,000,000 and (ii) the Capitalization (the "Performance Vesting Conditions"). As of December 18, 2020, the Company's Board of Directors determined the performance criteria had been met with respect to 18,750 additional shares.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
The option vests upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. As of October 1, 2020, the Company's Board of Directors determined the performance criteria had been met with respect to 37,500 shares.